DEA plan to stem supply of prescription drugs draws skepticism
(By Lev Facher for STAT) WASHINGTON — With pressure building on the the Drug Enforcement Administration to stem the supply
Read More
Part D/Prescription Drugs
AbbVie reaches deal that guarantees monopoly pricing for the next five years for Humira
AbbVie reached a deal with biopharmaceutical firm Samsung Bioepis that prevents Samsung from selling its cheaper copy of blockbuster drug
Read MorePhRMA spent almost $10 million lobbying to stop legislation to help generic companies
Faced with pressure from President Donald Trump’s administration and lawmakers on drug pricing, generic medicines and trade, the drug industry
Read MorePanel recommends FDA approval of epilepsy drug derived from marijuana
(By Andrew Joseph for STAT) An expert panel on Thursday unanimously recommended that the Food and Drug Administration approve a new medicine
Read MoreSafety violations at PharMEDium worsen hospital painkiller shortage
(By Megan Knowles for Becker’s Hospital Review) An investigation of PharMEDium, a major compounding pharmacy, revealed safety violations are worsening
Read MoreNation’s Top Doc Wants The Overdose Antidote Widely On Hand. Is That Feasible?
(By Shefali Luthra and Rachel Bluth for Kaiser Health News) When Surgeon General Jerome Adams issued an advisory calling for more people
Read MoreFederal Appeals Court Puts Chill On Maryland Law To Fight Drug Price-Gouging
(By Shefali Luthra for Kaiser Health News) States continue to battle budget-busting prices of prescription drugs. But a federal court
Read MoreCanadian online pharmacy fined for selling counterfeit drugs
United States prosecutors have fined a Canadian online pharmacy $34 million for importing counterfeit drugs and unapproved pharmaceuticals into the
Read MoreInnovative ways to pay for new antibiotics will help fight superbugs
(By Kevin Outterson for STAT) Antibiotics are the most important drug class in human history. Without them, minor infections like
Read MoreFDA Launches Criminal Investigation Into Unauthorized Herpes Vaccine Research
(By Marisa Taylor for Kaiser Health News) The Food and Drug Administration has launched a criminal investigation into research by
Read More